RxDoctor Payments DataLook up a doctor →

Amanda Nakashian

Women's Health · Dyer, INNPI 1558783019

Payments from drug & device makers

$7,564in general payments, 2019–2025

Across 347 payments — averaging $21.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Amgen$459
  • Johnson & Johnson$425
  • Astellas Pharma US Inc$402
  • Merck$388
  • Seagen Inc.$371
  • plus $5K from 48 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)52$1,008
Amgen22$459
Johnson & Johnson(2 entities)21$425
Astellas Pharma US Inc14$402
Merck19$388
Seagen Inc.14$371
Rigel Pharmaceuticals, Inc.15$306
Jazz Pharmaceuticals Inc.9$279
Eisai Inc.14$263
Novartis13$250
AbbVie12$247
GSK7$200
Incyte Corporation9$193
Pharmacyclics LLC, An Abbvie Company8$189
Regeneron Healthcare Solutions, Inc.7$175
Genentech USA, Inc.8$159
Daiichi Sankyo Inc.7$154
Sirtex Medical Inc1$146
Beigene USA, Inc.5$129
Lilly USA, LLC7$119
Sanofi7$117
Takeda Pharmaceuticals U.S.A., Inc.5$117
Tersera Therapeutics LLC4$114
Sobi, Inc6$102
Karyopharm Therapeutics Inc.4$92
Pfizer4$84
Servier Pharmaceuticals LLC4$75
Deciphera Pharmaceuticals Inc.4$71
Coherus Oncology, Inc.4$70
Array Biopharma Inc3$70
EMD Serono, Inc.3$54
Morphosys, US Inc.3$53
Sumitomo Pharma America, Inc.2$53
E.r. Squibb & Sons, L.L.C.2$50
Bristol Myers Squibb2$44
Pharmacosmos Therapeutics Inc.2$43
ADC Therapeutics America, Inc.2$43
Gilead2$40
Immunogen, Inc.2$40
Global Blood Therapeutics, Inc.2$36
Dova Pharmaceuticals2$35
Bayer2$32
Myovant Sciences Inc.1$29
Ipsen Biopharmaceuticals, Inc1$28
Adaptive Biotechnologies Corporation1$27
Blueprint Medicines Corporation1$25
Legend Biotech USA Inc.1$25
Azurity Pharmaceuticals, Inc.1$22
Scynexis, Inc.1$21
Alnylam Pharmaceuticals Inc.1$21
Foundation Medicine, Inc.1$18
Genmab U.S., Inc.1$17
Puma Biotechnology, Inc.1$17
AVEO Pharmaceuticals, Inc.1$17

How this compares

$7,564 in reported general payments places this provider in the 95th percentile of 142 women's health providers in Indiana.

See all women's health providers in Indiana →

Medicare billing

Part B allowed, 2024
$15,850
Medicare patients
91
Services billed
207

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other women's health in Dyer

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →